Core Insights - The Cigna Group announced a planned CEO transition, with David M. Cordani stepping down as CEO effective July 1, 2026, and Brian Evanko, the current president and COO, taking over as the new CEO [1][2] Group 1: CEO Transition - David M. Cordani has been CEO since 2009 and will serve as executive chair of the board after his transition [1] - Brian Evanko brings over 30 years of experience and currently oversees core segments including Cigna Healthcare and Evernorth Health Services [2] - Evanko's leadership is expected to focus on leveraging data, technology, and AI to modernize the company's operations [2] Group 2: Analyst Ratings - Bernstein analyst Lance Wilkes reiterated a Market Perform rating with a price target of $307.00 following the CEO transition announcement [2] - Wells Fargo maintained a Hold rating with a price target of $300, while J.P. Morgan reiterated a Buy rating without disclosing a price target [3] Group 3: Company Overview - The Cigna Group operates through several segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate [3]
The Cigna Group (CI) Announces CEO Transitions, Here’s What You Need to Know